FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
Body unavailable. Use the original source.
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death